The Lancet Psychiatry· Yoomi Park, Hasan Çağın Lenk, Yitian Zhou, Volker M Lauschke, Espen Molden·· 2026-10-01AI 评分45
CYP2D6 和 CYP2C19 基因型与文拉法辛治疗失败的相关性:来自挪威和英国的两项队列回顾性研究
[Articles] Association between CYP2D6 and CYP2C19 genotypes and venlafaxine treatment failure: a retrospective study on two cohorts from Norway and the UK
AI 导读
两项来自挪威和英国的大规模真实世界队列研究显示,CYP2D6 超慢代谢型(PM)状态与文拉法辛治疗失败风险增加持续相关。研究者认为,预防性基因分型有助于实现文拉法辛的个体化治疗。
来源:The Lancet Psychiatry · thelancet.com